Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5178486
Max Phase: Preclinical
Molecular Formula: C38H56N3O7P
Molecular Weight: 697.85
Associated Items:
ID: ALA5178486
Max Phase: Preclinical
Molecular Formula: C38H56N3O7P
Molecular Weight: 697.85
Associated Items:
Canonical SMILES: CC(C)C(NC(=O)[C@@H]1C[C@@H](C2CCCCC2)CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)P(=O)(Oc1ccccc1)Oc1ccccc1
Standard InChI: InChI=1S/C38H56N3O7P/c1-26(2)34(49(45,47-29-20-14-10-15-21-29)48-30-22-16-11-17-23-30)40-33(42)31-24-28(27-18-12-9-13-19-27)25-41(31)35(43)32(37(3,4)5)39-36(44)46-38(6,7)8/h10-11,14-17,20-23,26-28,31-32,34H,9,12-13,18-19,24-25H2,1-8H3,(H,39,44)(H,40,42)/t28-,31+,32-,34?/m1/s1
Standard InChI Key: GVCINVWKWAQOQC-LMMPKFLZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 697.85 | Molecular Weight (Monoisotopic): 697.3856 | AlogP: 8.17 | #Rotatable Bonds: 11 |
Polar Surface Area: 123.27 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.91 | CX Basic pKa: | CX LogP: 7.72 | CX LogD: 7.72 |
Aromatic Rings: 2 | Heavy Atoms: 49 | QED Weighted: 0.23 | Np Likeness Score: -0.04 |
1. Hwang J, Strange N, Mazraani R, Phillips MJ, Gamble AB, Huston WM, Tyndall JDA.. (2022) Design, synthesis and biological evaluation of P2-modified proline analogues targeting the HtrA serine protease in Chlamydia., 230 [PMID:35007862] [10.1016/j.ejmech.2021.114064] |
Source(1):